Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L29 pseudogene 21 (RPL29P21) is a processed pseudogene in the human genome, derived from the gene encoding ribosomal protein L29. Unlike the parent gene (RPL29), which codes for a core component of the 60S ribosomal subunit, RPL29P21 lacks the ability to code for a functional protein and is believed not to participate in protein synthesis or other known biological functions. Pseudogenes like RPL29P21 are typically genomic "fossils" that result from gene duplication and loss of coding capacity and are found dispersed throughout the genome. The parent gene, ribosomal protein L29 (RPL29), encodes a structural ribosomal subunit protein essential for protein synthesis and cell growth, but RPL29P21 does not share these properties. Processed pseudogenes may occasionally be transcribed or play regulatory roles, but no such functions have been described for RPL29P21 as of current databases and literature.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L29 pseudogene 21 (RPL29P21).